JP2009537601A5 - - Google Patents

Download PDF

Info

Publication number
JP2009537601A5
JP2009537601A5 JP2009511495A JP2009511495A JP2009537601A5 JP 2009537601 A5 JP2009537601 A5 JP 2009537601A5 JP 2009511495 A JP2009511495 A JP 2009511495A JP 2009511495 A JP2009511495 A JP 2009511495A JP 2009537601 A5 JP2009537601 A5 JP 2009537601A5
Authority
JP
Japan
Prior art keywords
neuropathic pain
mirtazapine
pharmaceutical composition
peripheral nerve
diabetic neuropathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009511495A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009537601A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/054872 external-priority patent/WO2007135123A2/en
Publication of JP2009537601A publication Critical patent/JP2009537601A/ja
Publication of JP2009537601A5 publication Critical patent/JP2009537601A5/ja
Pending legal-status Critical Current

Links

JP2009511495A 2006-05-22 2007-05-21 神経因性疼痛の治療用のミルタザピン Pending JP2009537601A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06114316 2006-05-22
PCT/EP2007/054872 WO2007135123A2 (en) 2006-05-22 2007-05-21 Mirtazapine for the treatment of neuropathic pain

Publications (2)

Publication Number Publication Date
JP2009537601A JP2009537601A (ja) 2009-10-29
JP2009537601A5 true JP2009537601A5 (enExample) 2010-07-01

Family

ID=37006417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009511495A Pending JP2009537601A (ja) 2006-05-22 2007-05-21 神経因性疼痛の治療用のミルタザピン

Country Status (8)

Country Link
EP (1) EP2026814A2 (enExample)
JP (1) JP2009537601A (enExample)
AR (1) AR061046A1 (enExample)
CA (1) CA2651607A1 (enExample)
MX (1) MX2008014287A (enExample)
PE (1) PE20080455A1 (enExample)
TW (1) TW200808804A (enExample)
WO (1) WO2007135123A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6452954B2 (ja) * 2013-05-16 2019-01-16 国立大学法人千葉大学 癌転移抑制剤
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211171B1 (en) * 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
HUP0204050A3 (en) * 2000-01-19 2004-09-28 Akzo Nobel Nv Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
US7074961B2 (en) * 2000-09-26 2006-07-11 The Brigham And Women's Hospital, Inc. Antidepressants and their analogues as long-acting local anesthetics and analgesics
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Similar Documents

Publication Publication Date Title
JP2013525444A5 (enExample)
CL2008000198A1 (es) Compuestos derivados de azacicloalcanos, inhibidores de estearoil-coenzima a delta-9; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como diabetes tipo 2, trastorno de lipidos, obesidad y aterosclerosis.
JP2010501534A5 (enExample)
ATE534378T1 (de) Titrierung von tapentadol
CY1115455T1 (el) Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
PT3133070T (pt) Eliglustat (genz 112638) como inibidor de glicosilceramida-sintase para utilização num método de tratamento de doença de fabry ou de gaucher, o método compreendendo ajustar a dose terapêutica individual ao metabolismo do p-450 do doente
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
JP2013519675A5 (enExample)
JP2015504870A5 (enExample)
BRPI0807285A2 (pt) "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto"
EP4327886A3 (en) Pyrimido- pyridazinone compounds and use thereof
CL2008000738A1 (es) Compuestos derivados de malonamida; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la depresion, enfermedad de parkinson y alzheimer, entre otras enfermeda
JP2015516419A5 (enExample)
WO2009007300A3 (en) Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture
JP2011046708A5 (enExample)
JP2010500284A5 (enExample)
WO2009003719A3 (en) Indane-amine derivatives, their preparation and use as medicaments
WO2007009720A3 (en) Prodrugs of pyrazoline compounds, their preparation and use as medicaments
WO2007098967A3 (en) Imidazole compounds having pharmaceutical activity towards the sigma receptor
JP2009537601A5 (enExample)
JP2014509637A5 (enExample)
JP2012518007A5 (enExample)
JP2012525422A5 (enExample)
JP2015509917A5 (enExample)